Latest researchEvidence window ending 2026-08-02

Latest Cancer Immunotherapy and Biomarkers research

Scollr indexed 1,208 new Cancer Immunotherapy and Biomarkers papers in the last 30 days and 5,640 in the last 90 days. Browse the most relevant recent papers below, then follow the topic in the app to turn this into a personalized research feed.

This week in Cancer Immunotherapy and Biomarkers

Evidence window ending 2026-06-15

Cancer Immunotherapy and Biomarkers shows 2,290 eligible recent papers and 2,277 commentary-ready papers in the current 30-day window, compared with 1,094 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers.

Recent publication activity is rising

Cancer Immunotherapy and Biomarkers recorded 2,290 eligible papers in the latest 30-day window, compared with 1,094 in the prior 30-day window, making the current snapshot up 109% from the prior window.

2,290 recent vs 1,094 prior eligible papers

Cancer Immunotherapy and Biomarkers anchors the current evidence

Cancer Immunotherapy and Biomarkers contributes 2,290 eligible recent papers, including 2,277 papers with abstracts available for commentary.

2,290 papers in the leading cluster

Representative papers show where the activity is concentrated

The representative set includes Immune Checkpoint Inhibitors: efficacy, safety, and biomarkers - a systematic review; Treatment and outcomes of immunotherapy related colitis and hepatitis- a multi-centre cohort study in the United Kingdom by the National Oncology Trainee Collaborative for Healthcare Research (NOTCH); Advances in Immune Checkpoint Inhibitors for Cancer Treatment; Severe immune checkpoint inhibitor-induced 3M syndrome: a case report; and Lymphocyte CD4/CD8 ratio predicts early immune-related toxicity in lung cancer patients treated with immune checkpoint inhibitors: a single-center retrospective study. These papers anchor the page's claims and keep the brief tied to visible evidence.

8 representative papers
Recent papers

Latest Cancer Immunotherapy and Biomarkers papers

The most relevant recent papers Scollr indexed in this topic, ranked by topic relevance, citations, and recency.

What is changing

What is changing in Cancer Immunotherapy and Biomarkers

Daily publication volume across the last 30 days, drawn from Scollr's indexed literature.

1,208last 30 days
4,432previous 60 days
1,203recent papers with abstracts
Active authors

Active authors in Cancer Immunotherapy and Biomarkers

Researchers publishing the most papers in this topic across the last 90 days.

Daisuke Tokita

28 recent papers

Hidekazu Tachibana

28 recent papers

Hiroki Ishihara

28 recent papers

Hironori Fukuda

28 recent papers

Junpei Iizuka

28 recent papers

Kazuhiko Yoshida

28 recent papers

FAQ

Keeping up with Cancer Immunotherapy and Biomarkers research

How do I keep up with new Cancer Immunotherapy and Biomarkers research?

Follow Cancer Immunotherapy and Biomarkers in Scollr. New papers in the topic flow into a personalized feed, and you can save the studies worth reading without setting up email alerts. This page also lists the most relevant recent papers so you can scan what changed at a glance.

What are the latest Cancer Immunotherapy and Biomarkers papers?

The recent papers section above is rebuilt continuously from Scollr's indexed literature, ranked by topic relevance, citations, and recency. Each links to its full record so you can read the abstract and follow the authors and sources behind it.

How do I find related work in Cancer Immunotherapy and Biomarkers?

Open any paper and build a literature map to see its references, citing papers, and related research in one workspace. The related topics list on this page also routes you into adjacent research areas Scollr tracks.